Exact Mass: 390.101409
Exact Mass Matches: 390.101409
Found 90 metabolites which its exact mass value is equals to given mass value 390.101409,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Dopaxanthin
Dopaxanthin is produce from the reaction between dopaxanthin quinone and water, with oxygen as the byproduct. The reaction is catalyzed by the tyrosinase precursor enzyme. Dopaxanthin can also be produced by the reaction between portulacaxanthin II, L-ascorbate, and O2, with L-dehydro-ascorbate and H2O as byproducts. The reaction is also catalyzed by the tyrosinase precursor enzyme. Dopaxanthin is produce from the reaction between dopaxanthin quinone and water, with oxygen as the byproduct. The reaction is catalyzed by the tyrosinase precursor enzyme.
5,7-Dihydroxy-2-(4-hydroxy-3-methoxy-phenyl)-3,6,8-trimethoxy-chromen-4-one
bicyclol
Clitoriacetal
5,3,4-Trihydroxy-3,6,7,8-tetramethoxyflavone
5,7,4-Trihydroxy-3,6,8,3-tetramethoxyflavone
3,5,4-Trihydroxy-6,7,8,3-tetramethoxyflavone
5,7,5-Trihydroxy-3,6,2,4-tetramethoxyflavone
3,5,8-Trihydroxy-6,7,3,4-tetramethoxyflavone
7-(4-Hydroxybenzoyl)-5-(hydroxymethyl)-4,5-dihydrospiro[benzofuran-2(3H),2(3H)-furan]-3,4,4,6-tetraol
Mangiferin; 1,3,6,7-Tetrahydroxy-2-beta(?)-glucosyl-xanthon
Squamatic acid
3,4-dihydro-7-hydroxy-4-(3,4-dihydroxyphenyl)-5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-2H-1-benzopyran-2-one|gnetumontanin E
2-(2-Oxopropyl)-7-(2-methyl-4,6-dihydroxybenzoyl)naphtho[1,8-bc]pyran-8-ol
5-Hydroxy-3-methoxy-6-acetoxy-4-methyl-2.2-oxy-dibenzoesaeure-1-methylester|6-Acetoxy-5-hydroxy-3-methoxy-4-methyl-2,2-oxy-di-benzoesaeure-1-methylester|6-acetoxy-5-hydroxy-3-methoxy-4-methyl-2,2-oxy-di-benzoic acid-1-methyl ester|6-(4-Hydroxy-6-methoxy-2-methoxycarbonyl-phenoxy)-2-acetoxy-4-methyl-benzoesaeure|Asterric acid-monoacetat
2,3,6,7-Tetra-Me ether-2,3,4,5,6,6,7-Heptahydroxyflavone|2,3,6,7-tetramethoxy-4,5,6-trihydroxyflavone|4,5,6-trihydroxy-2,3,6,7-tetramethoxyflavone|6,7,2,3-tetramethoxy-5,4,6-trihydroxyflavone|NAS-3
5,7-dihydroxy-2-(3-hydroxy-4,5-dimethoxyphenyl)-3,6-dimethoxy-4H-chromen-4-one
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, carboxymethyl methyl est
triethoxy-[3-(1,1,1,2,3,3,3-heptafluoropropan-2-yloxy)propyl]silane
LY2886721
C18H16F2N4O2S (390.09619799999996)
(2E)-1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-2-buten-1-one
C16H12F6N4O (390.09152539999997)
(3E)-1-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-3-buten-1-one
C16H12F6N4O (390.09152539999997)
Estra-1,3,5(10)-triene-3,16,17-triol,3-(hydrogen sulfate), sodium salt (1:1), (16a,17b)-
C18H23NaO6S (390.11129780000005)
2-(3,4-Dichlorophenyl)-1-(2-(pyrrolidin-1-ylmethyl)piperidin-1-yl)ethanone hydrochloride
N-[4-chloro-5-[(4-chlorophenyl)methyl]-6-methylpyrrolo[3,2-d]pyrimidin-2-yl]-2,2-dimethylpropanamide
3-[[[(1-Oxo-2,2-diphenylethyl)amino]-sulfanylidenemethyl]amino]benzoic acid
ethyl 2-anilino-5-(1H-indol-3-ylmethylene)-4-oxo-4,5-dihydro-3-thiophenecarboxylate
4-(4-Methoxyphenoxy)-2-(4-methylphenyl)-5-thiophen-2-yl-3-pyridazinone
1-[(1S,2aS,8bS)-4-(4-fluorophenyl)sulfonyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]ethanone
C19H19FN2O4S (390.10495060000005)
1-[(1R,2aS,8bS)-4-(4-fluorophenyl)sulfonyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]ethanone
C19H19FN2O4S (390.10495060000005)
1-[(1R,2aR,8bR)-4-(4-fluorophenyl)sulfonyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]ethanone
C19H19FN2O4S (390.10495060000005)
1-[(1S,2aR,8bR)-4-(4-fluorophenyl)sulfonyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]ethanone
C19H19FN2O4S (390.10495060000005)
6-[3-[(1E)-buta-1,3-dienyl]-1-oxoisochromen-5-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
[2-Hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] propanoate
5,7-Dihydroxy-2-(4-hydroxy-3-methoxy-phenyl)-3,6,8-trimethoxy-chromen-4-one
BRL 52537 (hydrochloride)
BRL 52537 hydrochloride is a highly selective κ-Opioid receptor (KOR) agonist with Kis of 0.24 nM and 1560 nM for κ and μ subtypes, respectively. BRL 52537 hydrochloride decreases ischemia-evoked NO production as a potential mechanism of neuroprotection. BRL 52537 hydrochloride attenuates early stroke damage[1].